Digital Pharma: NHS Facebook tracking under fire
November 26, 2010Medical Communications Digital Pharma blog, Facebook, online privacy, patient information
The government has been criticised for failing to protect patient confidentiality after it was revealed it allows Facebook to collect …
Novartis fails to sway NICE with Afinitor deal
November 26, 2010Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis, advanced renal cell carcinoma, everolimus
Novartis has failed to convince NICE that its revised patient access scheme for Afinitor would make the kidney cancer drug …
NHS Atlas shows health outcomes variation across England’s PCTs
November 26, 2010Sales and Marketing NHS, NHS Atlas, NHS reform, PCTs, Primary Care Trusts, healthcare variation, statin prescribing
A new tool will allow observers to compare at a glance what 152 Primary Care Trusts (PCTs) in England spend …
Interlace expands editorial and client services teams
November 26, 2010Medical Communications Becky Butlin, Interlace, Isobel Strang, Julianna Solomons, Raj Jangra, Sandra Boswell, Wells Healthcare, appointment, medical communications
Interlace Global Group has appointed eight new members of staff to its editorial and client services teams after winning five …
Complete Digital appoints Emma D’Arcy
November 26, 2010Business Services, Medical Communications Complete Digital, Emma D'Arcy, McCann Healthcare, appointment, medical communications, physician relationships, social media
Emma D’Arcy has joined McCann Healthcare’s Complete Digital group as a senior consultant. Emma has worked with pharmaceutical companies, the …
Pharma outsourcing recovering, but tough times are ahead
November 26, 2010Manufacturing and Production, Research and Development AAPS, American Association of Pharmaceutical Sciences, Jim Miller, Pharmsource, contract manufacturing, contract research, pharma outsourcing
There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …
Contract research news in brief
November 26, 2010Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research
Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …
Roche’s Sam Ogden joins the ABPI
November 25, 2010Medical Communications, Sales and Marketing ABPI, Sam Ogden, appointment, medical communications, sales and marketing
The ABPI has appointed Sam Ogden as membership engagement account director. She is currently head of in-field effectiveness at Roche …
Europe tightens patient information proposals
November 25, 2010Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information
European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …
Gilead’s pill shows promise in HIV prevention
November 25, 2010Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir
Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
UN says Treatment 2.0 approach needed for AIDS
November 25, 2010Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS
A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
Roche set to challenge NICE Tarceva decision
November 25, 2010Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer
NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …
The renal cell carcinoma market: Votrient to challenge Sutent’s lead
November 25, 2010Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma
After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …
GSK sells antibiotics assets to Dr Reddy’s
November 24, 2010Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK
Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
Varnish chemical migrates into medicine bottles, says study
November 24, 2010Manufacturing and Production AAPS, HDPE, chemical migration, varnish
A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …
Brain cancer vaccine to move into phase III
November 24, 2010Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma
Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
NICE recommends Herceptin for gastric cancer, blocks high dose Glivec
November 24, 2010Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer
NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …
Healthcare, politics and the NHS
November 24, 2010Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine
I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …
Pharma manufacturing news in brief
November 23, 2010Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche
Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …
Brinsmead to be life sciences adviser to government
November 23, 2010Sales and Marketing Brinsmead, NHS, government, life sciences
Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
